Haas, Tobias Longin
 Distribuzione geografica
Continente #
NA - Nord America 1.032
EU - Europa 753
AS - Asia 269
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.058
Nazione #
US - Stati Uniti d'America 1.030
SE - Svezia 313
CN - Cina 228
PL - Polonia 129
IT - Italia 93
IE - Irlanda 80
BE - Belgio 28
UA - Ucraina 27
DE - Germania 23
FR - Francia 22
GB - Regno Unito 19
TR - Turchia 17
IN - India 12
AT - Austria 6
VN - Vietnam 6
FI - Finlandia 4
NL - Olanda 4
RU - Federazione Russa 3
BR - Brasile 2
IR - Iran 2
JP - Giappone 2
CA - Canada 1
CH - Svizzera 1
CL - Cile 1
EU - Europa 1
HR - Croazia 1
IQ - Iraq 1
LK - Sri Lanka 1
PR - Porto Rico 1
Totale 2.058
Città #
Chandler 175
Warsaw 129
Fairfield 99
Dublin 80
Nanjing 61
Ashburn 57
Dearborn 56
Wilmington 52
Houston 45
Ann Arbor 41
Redmond 39
Princeton 38
Woodbridge 38
Cambridge 35
Jacksonville 34
Cattolica 32
Seattle 32
San Mateo 30
Brussels 28
Nanchang 21
Kunming 19
Shenyang 17
Rome 16
Hebei 15
Izmir 15
Redwood City 15
Beijing 14
Boston 14
Shanghai 11
Chicago 10
Changsha 9
Tianjin 9
Guangzhou 8
Hefei 8
Hangzhou 7
Mountain View 7
Norwalk 7
Dong Ket 6
San Diego 6
Vienna 6
Bremen 5
London 5
Marseille 5
Andover 4
Changchun 4
Falls Church 4
Gurgaon 4
Augusta 3
Chiswick 3
Genoa 3
Jiaxing 3
Zhengzhou 3
Boardman 2
Catanzaro 2
Changshahsien 2
Crick 2
Edinburgh 2
Fort Worth 2
Genova 2
Groningen 2
Gualdo Cattaneo 2
Helsinki 2
Kocaeli 2
Lanzhou 2
Pace del Mela 2
Phoenix 2
Verona 2
Wuhan 2
Baghdad 1
Benevento 1
Bergamo 1
Brindisi 1
Chaoyang 1
Chengdu 1
Colombo 1
Concepción 1
Curitiba 1
Falkenstein 1
Florence 1
Frankfurt am Main 1
Frederick 1
Fremont 1
Fuzhou 1
Harbin 1
Jinan 1
Kelheim 1
Kish 1
Lawrence 1
Lund 1
Miami 1
Mississauga 1
Nettuno 1
Ningbo 1
Parma 1
Rennes 1
Robbiate 1
Saint-sébastien-sur-loire 1
San Francisco 1
San Jose 1
San Juan 1
Totale 1.451
Nome #
The kinase inhibitor SI113 induces autophagy and synergizes with quinacrine in hindering the growth of human glioblastoma multiforme cells 239
Two-Step Co-Immunoprecipitation (TIP) Enables Efficient and Highly Selective Isolation of Native Protein-Complexes. 230
A pre-existing population of ZEB2+ quiescent cells with stemness and mesenchymal features dictate chemoresistance in colorectal cancer 122
Inhibitor of integrin for the treatment or prevention of tumours 119
Integrin α7 Is a Functional Marker and Potential Therapeutic Target in Glioblastoma 92
LUBAC is essential for embryogenesis by preventing cell death and enabling haematopoiesis 90
Antitumor effect of miR-197 targeting in p53 wild-type lung cancer 79
Integrin a7 Is a Functional Marker and Potential Therapeutic Target in Glioblastoma 78
Two-Step Coimmunoprecipitation (TIP) enables efficient and highly selective isolation of native protein complexes 68
Two-Step Co-Immunoprecipitation (TIP) 63
Identification of Targets to Redirect CAR T Cells in Glioblastoma and Colorectal Cancer: An Arduous Venture 58
LUBAC prevents lethal dermatitis by inhibiting cell death induced by TNF, TRAIL and CD95L 55
Integrin α7 Is a Functional Marker and Potential Therapeutic Target in Glioblastoma 55
Bortezomib sensitizes primary meningioma cells to TRAIL-induced apoptosis by enhancing formation of the death-inducing signaling complex 47
Lung cancer stem cells: Tools and targets to fight lung cancer 45
Antitumor effect of miR-197 targeting in p53 wild-type lung cancer 44
LUBAC is essential for embryogenesis by preventing cell death and enabling haematopoiesis 43
Linear ubiquitination prevents inflammation and regulates immune signalling 40
The linear ubiquitin chain assembly complex (LUBAC) forms part of the TNF-R1 signalling complex and is required for effective TNF-induced gene induction and prevents TNF-induced apoptosis 39
CD95 co-stimulation blocks activation of naive T cells by inhibiting T cell receptor signaling 37
Biochemical analysis of the native TRAIL death-inducing signaling complex 33
Apoptosis and Cancer Therapy: From Cutting-edge Science to Novel Therapeutic Concepts 33
Apoptosis mediated by lentiviral TRAIL transfer involves transduction-dependent and -independent effects 30
Polymeric substrates with tunable elasticity and nanoscopically controlled biomolecule presentation 29
Bortezomib sensitizes primary human astrocytoma cells of WHO grades I to IV for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis 27
Regulation of Enterocyte Apoptosis by Acyl-CoA Synthetase 5 Splicing 26
Biochemical analysis of the native TRAIL death-inducing signaling complex 26
The PEA-15/PED protein protects glioblastoma cells from glucose deprivation-induced apoptosis via the ERK/MAP kinase pathway 25
Small molecule XIAP inhibitors enhance TRAIL-Lnduced apoptosis and antitumor activity in preclinical models of pancreatic carcinoma 24
Recruitment of the Linear Ubiquitin Chain Assembly Complex Stabilizes the TNF-R1 Signaling Complex and Is Required for TNF-Mediated Gene Induction 24
Enhanced caspase-8 recruitment to and activation at the disc is critical for sensitisation of human hepatocellular carcinoma cells to trail-induced apoptosis by chemotherapeutic drugs 23
TRAIL/bortezomib cotreatment is potentially hepatotoxic but induces cancer-specific apoptosis within a therapeutic window 22
Suppression of cFLIP is sufficient to sensitize human melanoma cells to TRAIL- and CD95L-mediated apoptosis 22
Proteasome inhibition sensitizes hepatocellular carcinoma cells, but not human hepatocytes, to TRAIL 21
Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo 21
NF-kappaB inhibition reveals differential mechanisms of TNF versus TRAIL-induced apoptosis upstream or at the level of caspase-8 activation independent of cIAP2 20
Preclinical differentiation between apparently safe and potentially hepatotoxic applications of TRAIL either alone or in combination with chemotherapeutic drugs 20
Micro-nanostructured protein arrays: a tool for geometrically controlled ligand presentation 20
Specific resistance upon lentiviral TRAIL transfer by intracellular retention of TRAIL receptors 19
Identification of Targets to Redirect CAR T Cells in Glioblastoma and Colorectal Cancer: An Arduous Venture 6
Totale 2.114
Categoria #
all - tutte 6.678
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.678


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019177 0 0 2 4 20 43 72 4 0 7 19 6
2019/2020525 80 36 48 89 44 58 58 18 24 11 45 14
2020/2021186 12 13 24 8 36 11 18 5 14 15 20 10
2021/2022295 22 15 7 14 29 33 5 54 14 24 49 29
2022/2023659 124 102 65 58 59 67 27 45 65 14 19 14
2023/2024129 11 112 6 0 0 0 0 0 0 0 0 0
Totale 2.114